why choose us

First received: February 2, 2023

Clinical Trial: Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Tuberculosis

Study Type: Observational


Official Title: Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment

Brief Summary: Evaluate the possibility of using an IGRA (Interferon-? Release Assay) test for monitoring the response to anti-tuberculosis therapy by studying the correlation between the variation in the Interferon-gamma (IFN-?) response to the QFT-Plus test in the two tubes containing antigens and the gold standard for monitoring TB therapy (culture conversion) in patients with slide positive/culture positive and slide negative/culture positive PTB.Evaluate the level of agreement between the results of the new QFT Access test…

Read more